DF/HCC offers a variety of funding opportunities to members to encourage and enhance the collaborative spirit of research within the Harvard-affiliated medical community. Annual funding opportunities through DF/HCC have historically included pilot project awards through our Cancer Center development funding budget, SPORE career and project development awards, and jointly sponsored funding opportunities made available through our many partnerships with entities such as the Harvard Catalyst, the U54 DF/HCC UMass Boston Partnership, and the Harvard University Center for AIDs Research.

Two important funding programs have provided substantial opportunities to DF/HCC investigators recently. The Bridge Project, a collaboration between DF/HCC and the Koch Institute for Cancer Research at MIT, offers funding for teams that bring bioengineering, advanced cancer science, and clinical oncology together to address unmet clinical needs and technological solutions. The A. David Mazzone Research Awards Program funds a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases.

Active Funding Opportunities


df/hcc & Harvard Community Funding opportunity


DF/HCC Myeloid Malignancies SPORE CEP & DRP RFA's

Application due December 1, 2017

DF/HCC Breast Cancer SPORE CEP & DRP RFA's

Application due December 1, 2017 


External Funding Opportunity

Application Deadline

Doris Duke Charitable Foundation Clinical Scientist Development Award

Pre-proposal due December 1, 2017, Full proposal due March 16, 2018

AACR Gertrude B. Elion Cancer Research Award

Application due December 5, 2017 

Alex's Lemonade Stand 2018 Epidemiology Grant

Application due December 15, 2017

Alex's Lemonade Stand 2018 Innovation Grant

LOI due December 15, 2017, Application due April 2, 2018 

Alex's Lemonade Stand 2018 Young Investigator Grant

Application due December 15, 2017 
AACR SU2C Dream Team Translational Research Grant LOI due September 5, 2017, Application due January 1, 2018 
AACR Neuroendocrine Tumor Research Foundation Application due January 9, 2018 
CRI Focused Ultrasound and Cancer Immunotherapy Grant LOI due January 15, 2018, Application due March 1, 2018 

Damon Runyon Clinical Investigator Award – Institutional Nomination Required

Application due February 1, 2018

LLS Specialized Center of Research Program

LOI due October 2, 2017, Application due March 3, 2018 



Application Deadline

NCI Outstanding Investigator Award (R35) LOI due October 28, 2017, Application due November 28, 2017 
Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp) Application due December 12, 2017
Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54) LOI due December 18, 2017, Application due January 18, 2018
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) LOI due December 18, 2017, Application due January 18, 2018
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50 Clinical Trial Required)  LOI due December 24, 2017, Application due January 25, 2018
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) LOI due January 14, 2018, Application due February 14, 2018



Funding Opportunities & Archive